Clinical trial
Comparative Study on Fractionated Versus Bolus Dose of Hyperbaric Bupivacaine in Patients Undergoing Transurethral Resection of Prostate Surgery Under Subarachnoid Block.
NCT06620614 is registered in ClinicalTrials.gov with National Academy of Medical Sciences, Nepal as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Study on Fractionated Versus Bolus Dose of Hyperbaric Bupivacaine in Patients Undergoing Transurethral Resection of Prostate Surgery Under Subarachnoid Block.
- Lead sponsor
- National Academy of Medical Sciences, Nepal
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 1, 2022
- Completion date
- December 1, 2023
- Enrollment
- 72 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostatic hyperplasia, benign